P53 in kidney injury and repair: Mechanism and therapeutic potentials

Chengyuan Tang, Zhengwei Ma, Jiefu Zhu, Zhiwen Liu, Yuxue Liu, Yu Liu, Juan Cai, Zheng Dong

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Acute kidney injury (AKI) is a major kidney disease with poor clinical outcome. Besides its acute consequence of high mortality, AKI may also contribute significantly to the occurrence and progression of chronic kidney diseases (CKD). Accumulating evidence has demonstrated that maladaptive and incomplete kidney repair after AKI leads to the development of renal fibrosis and, ultimately, CKD. p53, a well-known tumor suppressor, plays a critical role in AKI and subsequent kidney repair through the regulation of various cell biologic processes, including apoptosis, cell cycle arrest, and autophagy. Despite the notable progress in deciphering the involvement of p53 in kidney injury and repair, the underlying mechanisms of p53 in these pathological processes remain largely unknown. Further investigation in this area is essential for the application of p53 as therapeutic target to prevent and treat AKI or impede its progression to CKD. In this review, we summarize the recent advances in understanding p53 regulation of AKI and kidney repair, pinpoint the potential of p53 as a therapeutic target, and present future research interests and directions.

Original languageEnglish (US)
Pages (from-to)5-12
Number of pages8
JournalPharmacology and Therapeutics
Volume195
DOIs
StatePublished - Mar 1 2019

Fingerprint

Acute Kidney Injury
Kidney
Wounds and Injuries
Chronic Renal Insufficiency
Therapeutics
Autophagy
Kidney Diseases
Pathologic Processes
Cell Cycle Checkpoints
Fibrosis
Apoptosis
Mortality
Neoplasms

Keywords

  • Acute kidney injury
  • Apoptosis
  • Autophagy
  • Cell cycle
  • Kidney repair
  • Renal fibrosis
  • p53

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

P53 in kidney injury and repair : Mechanism and therapeutic potentials. / Tang, Chengyuan; Ma, Zhengwei; Zhu, Jiefu; Liu, Zhiwen; Liu, Yuxue; Liu, Yu; Cai, Juan; Dong, Zheng.

In: Pharmacology and Therapeutics, Vol. 195, 01.03.2019, p. 5-12.

Research output: Contribution to journalReview article

Tang, Chengyuan ; Ma, Zhengwei ; Zhu, Jiefu ; Liu, Zhiwen ; Liu, Yuxue ; Liu, Yu ; Cai, Juan ; Dong, Zheng. / P53 in kidney injury and repair : Mechanism and therapeutic potentials. In: Pharmacology and Therapeutics. 2019 ; Vol. 195. pp. 5-12.
@article{65bfeba0781e4851b9d2e5c226404f5a,
title = "P53 in kidney injury and repair: Mechanism and therapeutic potentials",
abstract = "Acute kidney injury (AKI) is a major kidney disease with poor clinical outcome. Besides its acute consequence of high mortality, AKI may also contribute significantly to the occurrence and progression of chronic kidney diseases (CKD). Accumulating evidence has demonstrated that maladaptive and incomplete kidney repair after AKI leads to the development of renal fibrosis and, ultimately, CKD. p53, a well-known tumor suppressor, plays a critical role in AKI and subsequent kidney repair through the regulation of various cell biologic processes, including apoptosis, cell cycle arrest, and autophagy. Despite the notable progress in deciphering the involvement of p53 in kidney injury and repair, the underlying mechanisms of p53 in these pathological processes remain largely unknown. Further investigation in this area is essential for the application of p53 as therapeutic target to prevent and treat AKI or impede its progression to CKD. In this review, we summarize the recent advances in understanding p53 regulation of AKI and kidney repair, pinpoint the potential of p53 as a therapeutic target, and present future research interests and directions.",
keywords = "Acute kidney injury, Apoptosis, Autophagy, Cell cycle, Kidney repair, Renal fibrosis, p53",
author = "Chengyuan Tang and Zhengwei Ma and Jiefu Zhu and Zhiwen Liu and Yuxue Liu and Yu Liu and Juan Cai and Zheng Dong",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.pharmthera.2018.10.013",
language = "English (US)",
volume = "195",
pages = "5--12",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - P53 in kidney injury and repair

T2 - Mechanism and therapeutic potentials

AU - Tang, Chengyuan

AU - Ma, Zhengwei

AU - Zhu, Jiefu

AU - Liu, Zhiwen

AU - Liu, Yuxue

AU - Liu, Yu

AU - Cai, Juan

AU - Dong, Zheng

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Acute kidney injury (AKI) is a major kidney disease with poor clinical outcome. Besides its acute consequence of high mortality, AKI may also contribute significantly to the occurrence and progression of chronic kidney diseases (CKD). Accumulating evidence has demonstrated that maladaptive and incomplete kidney repair after AKI leads to the development of renal fibrosis and, ultimately, CKD. p53, a well-known tumor suppressor, plays a critical role in AKI and subsequent kidney repair through the regulation of various cell biologic processes, including apoptosis, cell cycle arrest, and autophagy. Despite the notable progress in deciphering the involvement of p53 in kidney injury and repair, the underlying mechanisms of p53 in these pathological processes remain largely unknown. Further investigation in this area is essential for the application of p53 as therapeutic target to prevent and treat AKI or impede its progression to CKD. In this review, we summarize the recent advances in understanding p53 regulation of AKI and kidney repair, pinpoint the potential of p53 as a therapeutic target, and present future research interests and directions.

AB - Acute kidney injury (AKI) is a major kidney disease with poor clinical outcome. Besides its acute consequence of high mortality, AKI may also contribute significantly to the occurrence and progression of chronic kidney diseases (CKD). Accumulating evidence has demonstrated that maladaptive and incomplete kidney repair after AKI leads to the development of renal fibrosis and, ultimately, CKD. p53, a well-known tumor suppressor, plays a critical role in AKI and subsequent kidney repair through the regulation of various cell biologic processes, including apoptosis, cell cycle arrest, and autophagy. Despite the notable progress in deciphering the involvement of p53 in kidney injury and repair, the underlying mechanisms of p53 in these pathological processes remain largely unknown. Further investigation in this area is essential for the application of p53 as therapeutic target to prevent and treat AKI or impede its progression to CKD. In this review, we summarize the recent advances in understanding p53 regulation of AKI and kidney repair, pinpoint the potential of p53 as a therapeutic target, and present future research interests and directions.

KW - Acute kidney injury

KW - Apoptosis

KW - Autophagy

KW - Cell cycle

KW - Kidney repair

KW - Renal fibrosis

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=85055173334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055173334&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2018.10.013

DO - 10.1016/j.pharmthera.2018.10.013

M3 - Review article

C2 - 30347214

AN - SCOPUS:85055173334

VL - 195

SP - 5

EP - 12

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

ER -